AtheroGenics is an emerging pharmaceutical company focused on thediscovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as asthma. The company has designed its lead product candidate, AGI-1067, as an oral drug to benefit patients with coronary artery disease. The company has combined its basic research in the role of blood vessels in inflammation with applied research techniques into an integrated process to discover new drugs for treating diseases of chronic inflammation.
# Employees: 57
Address: 8995 Westside Parkway,Alpharetta,GA,USA
Phone: 678 336-2500
Fax: 678 336-2501